Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT01392092 · ClinicalTrials.gov registry record
Effects of N-acetylcysteine on Brain Chemistry and Behavior in Cocaine Abusers (NAC)
A clinical trial, sponsored by Wayne State University.
- Completed
- Registry status
- 16
- Enrollment target
NCT01392092 is a clinical trial that has completed, run by Wayne State University. The registered enrollment target is 16 participants.
The verdict
NCT01392092 has completed, sponsored by Wayne State University.
- COMPLETED
- Registry status
- 16 participants
- Enrollment target
Study Summary
N-acetylcysteine (NAC) is a medication that the Food and Drug Administration (FDA) has approved for several medical uses, such as dissolving mucus in patients with breathing problems, treating overdose from acetaminophen (Tylenol), and protecting the kidneys from toxic substances. Some recent studies suggest that NAC could be useful in the treatment of other disorders including addictions. One purpose of this study is to determine whether NAC alters the level of brain glutamate (a chemical that excites brain cells). The other main purpose is to determine whether NAC affects how much cocaine people use.
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 16 participants |
| Start Date | 2011-07 |
| Est. Completion | 2017-06 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT01392092
The ClinicalTrials.gov registry entry for NCT01392092 describes a study currently listed as completed, categorized as an unspecified phase. The registered enrollment target is 16 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Wayne State University, which has 163 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 0 interventions.
NCT01392092 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT01392092 about?
NCT01392092 is a clinical study titled "Effects of N-acetylcysteine on Brain Chemistry and Behavior in Cocaine Abusers (NAC)". N-acetylcysteine (NAC) is a medication that the Food and Drug Administration (FDA) has approved for several medical uses, such as dissolving mucus in patients with breathing problems, treating overdose from acetaminophen (Tylenol), and protecting the kidneys from toxic substances. Some recent studi...
What is the current status of trial NCT01392092?
This trial is currently completed. The enrollment target is 16 participants. The study started on 2011-07. Estimated completion is 2017-06.
Who is sponsoring clinical trial NCT01392092?
This trial is sponsored by Wayne State University, which has 163 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.